Recombinant adeno-associated virus vector
AssigneeQuethera Limited
InventorsKenjiro ADACHI, Naoki KOZONO
Life of this patent
Estimating the term…
Abstract
Some embodiments relate to adeno-associated virus (rAAV) vectors, in particular rAAV vectors comprising a genetic construct harbouring genes encoding tyrosine receptor kinase B and Brain Derived Neurotrophic Factor. The presently disclosed subject matter also extends to a pharmaceutical composition comprising the rAAV vectors, and to the use of such vectors and compositions in gene therapy methods for preventing or treating a range of optic nerve disorders and cochlear disorders, or for promoting nerve regeneration and/or survival. The presently disclosed subject matter also provides methods of producing the rAAV vectors.
Claims24
A recombinant adeno-associated virus (rAAV) vector comprising a genetic construct comprising, in a 5′ to 3′ orientation:
- a cytomegalovirus (CMV) promoter;
- a first coding sequence, which encodes tyrosine kinase receptor B (TrkB);
- a nucleotide sequence encoding a linker to generate TrkB and mature brain-derived neurotrophic factor (mBDNF) as individual proteins;
- and
- a second coding sequence, which encodes mBDNF,
- wherein the CMV promoter is operably linked to the first and second coding sequences.
Dependencies are inferred from the claim text.